Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mise

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1990
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancerT Okino, N Kan, M Nakanishi, et al.
Nihon Gan Chiryo Gakkai Shi|March 20, 1990
[Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes]T Okino, N Kan, K Mise, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[The therapeutic effects of OK-432 combined adoptive immunotherapy (AIT) against liver metastases of breast cancer]T Okino, N Kan, M Nakanishi, et al.
Blood|November 1, 1987
Reciprocal translocation involving the short arms of chromosomes 7 and 11, t(7p-;11p+), associated with myeloid leukemia with maturationY Sato, S Abe, K Mise, et al.
American Journal of Clinical Oncology|October 20, 2000
Results of breast-conserving therapy for early stage breast cancer: Kyoto University experiencesM Kokubo, M Mitsumori, S Ishikura, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapyS Yamasaki, T Okino, N Kan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosisK Mise, S Tashiro, S Yogita, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factorN Kan, K Mise, M Nakanishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]N Kan, T Okino, M Nakanishi, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapyS Yamasaki, N Kan, K Mise, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Cancer Research and Clinical Oncology|January 1, 1990
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from breast cancerT Okino, N Kan, M Nakanishi, et al.
Nihon Gan Chiryo Gakkai Shi|March 20, 1990
[Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes]T Okino, N Kan, K Mise, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[The therapeutic effects of OK-432 combined adoptive immunotherapy (AIT) against liver metastases of breast cancer]T Okino, N Kan, M Nakanishi, et al.
Blood|November 1, 1987
Reciprocal translocation involving the short arms of chromosomes 7 and 11, t(7p-;11p+), associated with myeloid leukemia with maturationY Sato, S Abe, K Mise, et al.
American Journal of Clinical Oncology|October 20, 2000
Results of breast-conserving therapy for early stage breast cancer: Kyoto University experiencesM Kokubo, M Mitsumori, S Ishikura, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Factors influencing the response and survival of patients with liver metastases from breast cancer receiving OK-432-combined adoptive immunotherapyS Yamasaki, T Okino, N Kan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosisK Mise, S Tashiro, S Yogita, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factorN Kan, K Mise, M Nakanishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1989
[Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]N Kan, T Okino, M Nakanishi, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapyS Yamasaki, N Kan, K Mise, et al.
Pageof 12